Treatment and Management of MDS in the Era of Precision Medicine

SELF STUDY / ENDURING - ESTIMATED TIME TO COMPLETE ACTIVITY: 60 Minutes

MDS often has a detrimental impact on patients and puts them at an increased risk of progressing to acute myeloid leukemia. Though MDS is relatively rare, clinician understanding of diagnosing and managing patients is imperative to patient health and quality of life. During this webcast, expert faculty discuss the diagnosis and treatment of myelodysplastic syndromes in the light of precision medicine including prognostic markers and novel therapies.

Target Audience

This CME initiative was designed for oncologists, surgeons, radiation oncologists, NPs, PAs, pharmacists, nurses, and other healthcare professionals involved in the treatment of patients with cancer.

Learning Objectives

1. Recognize the molecular and genetic characterization of myelodysplastic syndromes (MDS) to better understand disease pathophysiology
2. Discuss prognostic markers to determine treatment plans for patients with MDS
3. Describe the efficacy and safety of the most recent advancements in therapeutic approaches for MDS
Identify strategies to optimize safety and tolerability of novel therapies

Course summary
Available credit: 
  • 0.50 AMA PRA Category 1 Credit™
    Horizon CME designates this Enduring activity for a maximum of 0.50 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
  • 0.50 ANCC
    This activity has been planned and implemented in accordance with the accreditation requirements and policies of the American Nurses Credentialing Center’s Commission on Accreditation through the joint providership of the Nurse Practitioner Healthcare Foundation and Horizon CME. The Nurse Practitioner Healthcare Foundation is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center’s Commission on Accreditation. NPHF is awarding the contact hours and is responsible for adherence to the ANCC criteria. This course is approved by the Nurse Practitioner Healthcare Foundation, California Board of Registered Nursing, CEP# 16441. Upon completion, NPs and RNs will be awarded up to 0.50 credit.
Course opens: 
03/15/2023
Course expires: 
03/15/2024
Cost:
$0.00
Rating: 
0

Faculty

Apryl Sarabia, MSHS, PA-C

Apryl Sarabia graduated from Cornell University with a B.S. in Human Biology in 2007 and a M.S. in Healthcare Sciences for Physician Assistants in 2011. Her clinical expertise is in hematologic malignancies and stem cell transplantation. She has worked in various clinical roles at leading healthcare facilities, including Memorial Sloan Kettering Cancer Center, New York Presbyterian Hospital, and Kaiser Permanente. Apryl has served as a Board of Director and Scholarship Committee Chair for the Association of Physician Assistants in Oncology. She is passionate about training and mentoring Advanced Practice Providers new to the field of oncology. In her free time, Apryl is an avid and adventurous traveler.

Disclosures:

In accordance with the ACCME Standards for Integrity and Independence in Accredited Continuing Education, Horizon CME (HCME) ensures that continuing education activities are balanced, independent, objective, and scientifically rigorous. 

All persons in a position to influence the content of an accredited continuing education activity provided by Horizon CME are required to disclose to HCME any relevant financial relationships with ineligible companies within the past 24 months. All reported relevant financial relationships have been mitigated by Horizon CME.

Apryl Sarabia, MSHS, PA-C  discloses no relevant financial relationships with any entity producing, marketing, re-selling, or distributing health care goods or services consumed by, or used on, patients during the past 24 months.

Available Credit

  • 0.50 AMA PRA Category 1 Credit™
    Horizon CME designates this Enduring activity for a maximum of 0.50 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
  • 0.50 ANCC
    This activity has been planned and implemented in accordance with the accreditation requirements and policies of the American Nurses Credentialing Center’s Commission on Accreditation through the joint providership of the Nurse Practitioner Healthcare Foundation and Horizon CME. The Nurse Practitioner Healthcare Foundation is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center’s Commission on Accreditation. NPHF is awarding the contact hours and is responsible for adherence to the ANCC criteria. This course is approved by the Nurse Practitioner Healthcare Foundation, California Board of Registered Nursing, CEP# 16441. Upon completion, NPs and RNs will be awarded up to 0.50 credit.

Price

Cost:
$0.00
Please login or register to take this course.

There are no fees for participating and receiving CME credit for this enduring activity. To receive CME credit participants must:

  1. Read the CME/CE information and faculty disclosures.
  2. Participate in the online activity.
  3. Complete the post-test and score a minimum of 70%
  4. Submit the evaluation form

DISCLAIMER:

This activity is designed for educational purposes. Participants have a responsibility to utilize this information to enhance their professional development to improve patient outcomes. Conclusions drawn by the participants should be derived from careful consideration of all available scientific information. The participant should use his/her clinical judgment, knowledge, experience, and diagnostic decision-making before applying any information, whether provided here or by others, for any professional use.

Required Hardware/software

Access to the internet is required.

Supported Browsers:

Internet Explorer 8.0+ for Windows 2003, Vista, XP, Windows 7, Windows 8.1 and above

Google Chrome 28.0+ for Windows, Mac OS, or Linux

Mozilla Firefox 23.0+ for Windows, Mac OS, or Linux

Safari 6.0+ for Mac OSX 10.7 and above

 

Supported Phones & Tablets:

 Android 4.0.3 and above

iPhone/iPad with iOS 6.1 or above